Skip to content
Trial Eligibility
Menu

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

NCT06898034

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Up to 5% of patients in the United States have a postpartum hemorrhage. "Postpartum hemorrhage" means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the "medium-term" (1.5-24 hours after delivery). Investigators are examining whether ultrasound exams performed at the beginning of this period 1.5 to 2 hours after birth can identify markers that predict a medium-term bleed.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pregnancy Related
  • Post Partum Hemorrhage

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
17 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
Endeavor Health
Last updated on ClinicalTrials.gov
March 27, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Endeavor Health · Evanston, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.